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Metal nanoparticles (NPs) scatter and absorb light in precise, designable ways, making them agile candidates for a
variety of biomedical applications. When NPs are introduced to a physiological environment and interact with cells,
their physicochemical properties can change as proteins adsorb on their surface and they agglomerate within
intracellular endosomal vesicles. Since the plasmonic properties of metal NPs are dependent on their geometry and
local environment, these physicochemical changes may alter the NPs' plasmonic properties, on which applications
such as plasmonic photothermal therapy and photonic gene circuits are based. Here we systematically study and
quantify how metal NPs' optical spectra change upon introduction to a cellular environment in which NPs
agglomerate within endosomal vesicles. Using darkfield hyperspectral imaging, we measure changes in the peak
wavelength, broadening, and distribution of 100-nm spherical gold NPs' optical spectra following introduction to
human breast adenocarcinoma Sk-Br-3 cells as a function of NP exposure dose and time. On a cellular level, spectra
shift up to 78.6 ± 23.5 nm after 24 h of NP exposure. Importantly, spectra broaden with time, achieving a spectral
width of 105.9 ± 11.7 nm at 95% of the spectrum's maximum intensity after 24 h. On an individual intracellular NP
cluster (NPC) level, spectra also show significant shifting, broadening, and heterogeneity after 24 h. Cellular transmission
electron microscopy (TEM) and electromagnetic simulations of NPCs support the trends in spectral changes we
measured. These quantitative data can help guide the design of metal NPs introduced to cellular environments in
plasmonic NP-mediated biomedical technologies.
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By virtue of their size and unique optical properties,
metal nanoparticles (NPs) have enabled the development
of numerous diagnostic and therapeutic technologies,
such as contrast-enhanced medical imaging, plasmonic
photothermal cancer therapy (PTT), and light-activated
photothermal release of biomolecules [1-6]. While these
technologies are extremely promising, their successful
clinical adoption requires a clearer understanding of
how NPs interact with the biological environment in* Correspondence: drezek@rice.edu
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in any medium, provided the original work is pwhich NPs are introduced. Already, studies have demon-
strated how NPs' physicochemical properties (e.g., size
and surface charge) can change when NPs are intro-
duced into biological media and thus impact NP behav-
ior. For example, proteins in the blood or cell culture
medium can adsorb onto the NP surface, increasing NP
size by as much as a factor of two [7,8], altering the sur-
face charge [7-9], and under different conditions either
preventing [10,11] or facilitating [12,13] inter-particle
aggregation. These new surface and structural properties
can consequently determine which cell types NPs are
targeted to [14], the extent of cellular uptake [15-19],
and where NPs localize within cells [7,16]. It is therefore
evident that the property changes experienced by NPs in
a biological environment must be well-understood soOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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biomedical contexts.
One NP property whose changes have thus far not
been well-studied in a biological environment is the
metal NP optical response. When optically excited,
metal NPs support a collective oscillation of surface
electrons (termed ‘plasmon’), which is manifested as a
strong interaction with light in terms of both absorption
and scattering. The wavelength at which this optical re-
sponse is strongest, termed the localized surface plas-
mon resonance wavelength, is very sensitive to the NP
geometry and surrounding environment [20]. Both of
these factors can change when NPs are internalized by
cells, suggesting that the optical properties of NPs may
be impacted. Specifically, during receptor-mediated
endocytosis of NPs, NPs are sequestered into subcellular
endosomes and trafficked to late endosomes and lyso-
somes, where increasing numbers of NPs accumulate
and possibly agglomerate [21,22]. Intracellular agglomer-
ation of NPs should alter the NP plasmonic spectra be-
cause from a fundamental plasmonics viewpoint, placing
metal NPs in close proximity to each other can result in
electromagnetic coupling of their plasmons and lead to a
shift of the plasmon resonance wavelength to longer
wavelengths (‘red-shift’) [23-25]. A red-shift of plas-
monic NP spectra following NP agglomeration within
cells has indeed been noticed in some studies. For in-
stance, while developing anti-EGFR-conjugated gold NPs
(AuNPs) as biosensors for measuring intracellular re-
fractive index, Curry et al. observed that the scattering
peaks for antibody-free AuNPs red-shifted and had a
broader distribution than those for antibody-conjugated
AuNPs following incubation with A431 cells [26]. Be-
cause transmission electron microscopy (TEM) showed
that antibody-free AuNPs were aggregated in cells and
the antibody-conjugated AuNPs were singular, Curry
et al. noted that the aggregation of antibody-free AuNPs
in cells contributed to a red-shift in spectra [26]. Re-
cently, red-shifting in the spectra of gold nanorods
(AuNRs) in a pellet of MDA-MB-231 cells has also been
observed [27]. While these observations have suggested
that the optical properties of plasmonic NPs can change
in a cellular environment, such spectral changes have
not yet been quantified or systematically studied, making
it difficult to assess whether such changes are important
to consider in the future design of plasmonic NPs for
biomedical applications.
Quantitative knowledge of how the NP spectra and
plasmon resonance wavelength change in a cellular en-
vironment can inform many in vitro and in vivo plas-
monic NP-mediated applications. For instance, in PTT,
metallic nanostructures are excited at their plasmon res-
onance maximum to cause localized absorption, heating,
and destruction of cancer tissue. The NP geometry isdesigned such that the peak resonance wavelength mea-
sured in solution coincides with the emission wavelength
of the laser used [4,28]. However, because the magnitude
of spectral shift resulting from intracellular clustering
has not been quantified, it is unknown how much of a
mismatch with the laser emission wavelength can arise
and if it is significant to consider. Researchers have pro-
posed utilizing the intracellular NP agglomeration effect
so that simple solid spherical AuNPs that are restricted
to resonance at visible wavelengths can be excited for
PTT with infrared wavelengths within the biological
transparency window after agglomeration in vivo [29-32].
Plasmonic nanostructures are also employed in in vitro
studies to study biological processes by using plasmon res-
onance energy transfer (PRET) [33]. The presence of a
biomolecule with an absorption peak coinciding with the
resonance peak of a plasmonic NP probe is detected by a
dip in the probe's plasmon resonance spectrum [33]. Since
the resonance of the NP probe must match the absorption
of the molecule of interest for PRET to work, understand-
ing the conditions under which the NP probe resonance
may shift upon cellular uptake would help ensure accur-
acy of PRET. Finally, plasmonic NPs are being explored
for multiplexing as multicolor labels for molecular im-
aging [34,35] or antennas for photonic gene circuits [36].
In demonstrating the potential of photonic gene circuits,
Lee et al. showed that two AuNR antenna populations
functionalized with small interfering RNA (siRNA) could
differentially release siRNA and thus turn gene circuits
‘off ’ or ‘on’ upon excitation with light at one nanorod
population's resonance wavelength [36]. However, there
was some release of siRNA from the nanorod antenna
population that was non-resonant at the light wavelength
illuminating the cells [36]. This crosstalk suggests the po-
tential importance of developing methods to fabricate NPs
with narrower resonances and considering possible spec-
tral changes in a cellular environment when designing the
plasmon resonance characteristics of NP antennas.
In this paper, we systematically investigate and quan-
tify changes in the spectra of metal NPs in situ following
their introduction to a cellular environment in order to
inform optimized design of NPs for plasmonic NP-
mediated biomedical applications. Using darkfield hyper-
spectral (HS) imaging, we measure optical spectra of NP
clusters (NPCs) on the cell level and intracellular NPC
level, and we quantify how the spectra's peak wavelength
changes with time and NP exposure dose. We also
characterize spectral broadening since its magnitude will
impact the range of illumination wavelengths that can
be used to excite NPs in a cellular environment as well
as the ability for NPs to be multiplexed without spectral
overlap. We find that the spectral shift is both time- and
dose-dependent, accruing a maximum shift of 78.6 ±
23.5 nm between 2 and 24 h of NP incubation with cells,
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ing a width of about 105 nm at 95% of the spectrum's
maximum intensity. The quantitative analysis and char-
acterization of how the NPs' spectral peak wavelength
and spectral broadness change upon interaction with
cells will help guide NP design for maximal efficacy and
safety in biological environments.
Methods
HS imaging of AuNPs in varying refractive indices
Glass slides were cleaned using piranha acid (7:3 mixture
of sulfuric acid to hydrogen peroxide. Caution: very
strong acid and oxidizer!) for 15 min followed by ethanol
and DI water rinses. Slides were then immersed in 10%
(3-mercaptopropyl)trimethoxysilane (MPTMS) in etha-
nol for at least 4 h, rinsed with ethanol, and dried with
N2 gas. MPTMS-functionalized slides were baked at 80°C
for 30 min to strengthen the glass-silane bond and kept in
ethanol until use. A uniform submonolayer of NPs was
immobilized on the slides by immersing slides in 20 mL of
1.12 × 109 NP/mL 100-nm citrate-stabilized spherical
AuNPs (Ted Pella, Redding, CA, USA) for 90 min on an
orbital shaker, rinsing with ethanol and ultrapure water
(Milli-Q, Millipore, Billerica, MA, USA), and drying with
N2 gas. HS images were collected for the same NP sub-
strate with air (n = 1.00), water (n = 1.33), or glycerol (n =
1.47) present between the top of the substrate and the
cover slip. The same field of view (defined by the coordi-
nates of a motorized stage) was observed under each con-
dition, and the substrate was rinsed with Milli-Q and
dried with a gentle stream of N2 gas before each switch
into another refractive index medium.
Mie calculations
Mie calculations were performed using a MATLAB code
adapted for light scattering from concentric spheres. Ex-
tinction, scattering, and absorption coefficients were cal-
culated based on Mie scattering coefficients. Plane-wave
illumination was assumed to obtain the Mie coefficients.
This assumption is justified by our use of subdiffraction-
limit sized AuNPs and the fact that they were located far
from the illuminating objective compared to the wave-
length of visible light. Gold properties were adapted
from Johnson and Christy [37].
Characterizing spectral shift of NPs from water to CPRFM
To assess initial changes to the NP spectra upon incuba-
tion in complete phenol red-free cell culture media
(CPRFM) prior to cellular uptake, extinction spectra of
NPs before and after transfer to CPRFM was measured
with an Agilent Cary 60 UV-vis spectrophotometer.
CPRFM consisted of phenol red-free McCoy's 5A media
(HyClone, Waltham, MA, USA) containing 10% v/v hu-
man off-the-clot type AB serum (PAA Laboratories,Pasching, Austria) and 1% penicillin-streptomycin (Sigma-
Aldrich, St. Louis, MO, USA). Citrate-stabilized spherical
AuNPs (100 nm, Ted Pella, Redding, CA, USA) were cen-
trifuged, redispersed in CPRFM, and incubated at 37°C in
5% CO2 in a cell culture incubator. NPs in water (negative
control) and CPRFM alone were also kept under same
conditions. All spectra were collected with water as the
baseline. Spectra for CPRFM alone were measured at each
time point and subtracted from the corresponding spectra
of NPs incubated in CPRFM.
Measuring optical spectra for NPs introduced to cellular
environment
Sk-Br-3 cells (American Type Culture Collection, Manassas,
VA, USA) were cultured in McCoy's 5A media supple-
mented with 10% v/v human off-the-clot type AB serum
and 1% penicillin-streptomycin and maintained at 37°C in
a 5% CO2 incubator. Sk-Br-3 cells were plated on Lab-Tek
II CC2 4-well chamber slides at a density of 100,000 cells/
well and grown to 70% confluence. After 24 h, culture
media was removed and cells were incubated with AuNPs
in CPRFM for 2, 5, 10, or 24 h in an incubator at 37°C
and 5% CO2. AuNPs in CPRFM were prepared by centri-
fuging citrate-stabilized AuNPs (100 nm, Ted Pella,
Redding, CA, USA) at 2,000 g for 20 min, redispersing in
CPRFM, sonicating, passing through a 0.22-μm polyether-
sulfone (PES) sterile filter (Millipore, Billerica, MA, USA),
and diluting in CPRFM to final concentrations of 12, 24,
48, or 96 μg/mL. Following incubation, cells were rinsed
3x with 1X Dulbecco's phosphate-buffered saline without
magnesium and calcium (PBS, Invitrogen, Life Technolo-
gies, Grand Island, NY, USA), fixed using 4% formalde-
hyde (15 min, BD Biosciences, San Jose, CA, USA), and
rinsed again 2x with PBS. Chamber slides with cells and
internalized NPs were then wetted with PBS, covered with
a cover slip, sealed with nail polish, and viewed under an
Olympus BX-41 upright microscope (Olympus, Center
Valley, PA, USA) coupled with a CytoViva high-resolution
illuminator at 40x magnification (Plan Fluorite, 0.75 NA,
Olympus, Center Valley, PA, USA).
Spectral data across the sample field of view were col-
lected using the hyperspectral imaging system connected
to the CytoViva microscope (CytoViva, Auburn, AL,
USA). Samples were illuminated with a quartz halogen
lamp with aluminum reflector (400 to 1,000 nm) and
spectral data cubes were obtained by automated move-
ment of the sample using a X-Y motorized stage (Prior,
Rockland, MA, USA) across a transmission diffraction
grating spectrograph with 2.8-nm resolution (Specim,
Oulu, Finland). Darkfield HS images were taken at the
slide plane as well as 5 μm above the slide plane (con-
trolled by a Prior motorized z focus drive with 0.002-μm
minimum step size; see Additional file 1 for more de-
tails). HS images were analyzed using the instrument's
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CO, USA). Cell regions of interest (ROIs) were defined by
tracing the outline of cells with the polygon ROI tool. In
order to objectively define ROIs without bias toward cells
that appeared to have greater uptake of NPs, all cells in
each HS image were identified as long as the cell boundar-
ies could be unambiguously identified. NPC ROIs were
defined by selecting 12-pixel ellipse-shaped ROIs encom-
passing the image pixels for NPCs (see Additional file 1
for details). Spectral data averaged across the pixels of
each ROI was extracted by the ENVI software. The spec-
tral data was calibrated for variations in lamp intensity by
dividing by the normalized lamp spectrum.
Peak wavelength determination
Spectral peak wavelengths were objectively determined
using the peak analyzer function of OriginPro 8.6 Data
Analysis and Graphing Software (OriginLab, Northampton,
MA, USA). Savitzky-Golay smoothing with a window size
of 50 was first performed on spectral data followed with
peak finding using a local maximum method with two
local points. Calculated peak wavelengths were then
manually checked against the plotted spectra to confirm
accuracy. When spectra contained multiple peaks, the
peak with higher intensity was analyzed.
Since peak wavelength could not be accurately identi-
fied in spectra that were dominated by cell scattering
and had insufficient NP plasmonic spectra contributions,
we excluded these spectra in our analysis. To objectively
classify which spectra lacked sufficient signal for ana-
lysis, we inspected the spectra's normalized intensity at
500 nm. Spectra that had a normalized intensity at
500 nm of 0.95 or higher were deemed cell scattering-
dominated and thus not included in the analysis.
Peak broadening measurement
A custom program was created in MATLAB to smooth
and calculate the peak broadening of the spectra. Spec-
tral data was first smoothed using a Savitzky-Golay algo-
rithm (chosen to maximally preserve the spectral shape
and intensity) of degree 2. All points in the smoothed
spectrum were then shifted downward by a constant
value equivalent to 95% of the spectrum's maximum in-
tensity. The smoothed and shifted spectrum's two points
of zero crossing represented the span of the spectrum at
95% of the spectrum's maximum intensity. The width of
the spectrum at 95% of the maximum intensity was then
calculated by taking the difference of the two points of
zero crossing.
Evaluating cell viability
Cell viability after incubation with NPs was evaluated by
performing a Live/Dead viability assay (Life Technolo-
gies, Grand Island, NY, USA). Following NP exposure,cells were rinsed 3x with PBS, incubated with Live/Dead
reagent for 15 min at room temperature, and imaged at
20x magnification with a Zeiss Axio Observer.A1m
inverted fluorescence microscope (Zeiss, Jena, Thuringia,
Germany). Live cells and dead cells were visualized using
filters with the following excitation and emission specifi-
cations: Ex 480 ± 20 nm/Em 535 ± 25 nm and Ex 560 ±
27.5 nm/Em 645 ± 37.5 nm (Chroma, Bellows Falls, VT,
USA), respectively. Numbers of live and dead cells were
counted using ImageJ (National Institutes of Health, Be-
thesda, MD, USA). Cell viability was determined as
number of live cells/number of total cells × 100%.Cellular TEM
Following incubation with NPs, cells were rinsed 3x with
1X PBS, fixed with 2.5% formaldehyde/2.5% glutaralde-
hyde in 0.1 M sodium cacodylate buffer (Electron Micros-
copy Sciences, Hatfield, PA, USA) at room temperature,
and kept at 4°C overnight. After fixation, the samples were
washed in 0.1 M cacodylate buffer and treated with 0.1%
Millipore-filtered buffered tannic acid, postfixed with 1%
buffered osmium tetroxide for 30 min, and stained en bloc
with 1% Millipore-filtered uranyl acetate. The samples
were washed several times in water, then dehydrated in in-
creasing concentrations of ethanol, infiltrated, and embed-
ded in Spurr's low-viscosity medium. The samples were
polymerized in a 60°C oven for 2 days. Ultrathin sections
were cut in a Leica Ultracut microtome (Leica, Buffalo
Grove, IL, USA), stained with uranyl acetate and lead cit-
rate in a Leica EM stainer (Leica, Buffalo Grove, IL, USA),
and examined in a JEM 1010 transmission electron micro-
scope (JEOL USA, Inc., Peabody, MA, USA) at an acceler-
ating voltage of 80 kV. Digital images were obtained using
AMT Imaging System (Advanced Microscopy Techniques
Corp, Woburn, MA, USA).Electric field simulation
The electric field was calculated using the RF module in
COMSOL Multiphysics. The simulation geometry con-
sisted of a spherical far-field scattering domain with a ra-
dius of 500 nm, a perfectly matched layer of 350-nm
thickness, and clusters of AuNPs whose center coordi-
nates are supplied in Additional file 1: Table S2. Gold
properties were adapted from Johnson and Christy [37].
The refractive index of water was set to 1.33. The scat-
tered field was calculated with a background electric
field linearly polarized in the x direction and propagating
in the z direction. The definition of the E-field with
respect to the AuNP cluster geometry is shown in
Additional file 1: Figure S11. Direct solvers were used
for the simulation. Computation was performed by a
workstation equipped with dual 6-core Intel Xeon
X5690 3.46 GHz processors and 144 GB of RAM. The
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plane) of the cluster.
Statistical analysis
In comparisons of spectral peak wavelengths or spectral
widths among different NP exposure times and doses,
statistical significance was evaluated by performing one-
factor analysis of variance (ANOVA) followed by a post
hoc Tukey's HSD test for multiple comparisons. P values
less than 0.01 were considered statistically significant.
Results and discussion
For this study, we chose 100-nm spherical AuNPs as our
model plasmonic NP because their plasmonic spectra
are well-characterized, they have a large scattering cross
section, and plasmonic nanostructure-based biomedical
applications commonly utilize NPs in this size regime
[1,38,39]. In addition, the extinction and scattering spec-
tral profiles of 100-nm AuNPs are similar (Additional
file 1: Figure S1), enabling comparison between darkfield
HS imaging scattering spectra and UV-vis spectroscopy
extinction spectra. We employed darkfield HS imaging
to measure NPC spectra in a cellular context since it al-
lows for spectral image cubes to be captured in which
full reflectance spectra can be extracted from each pixel
of the image. Darkfield HS imaging has been previously
utilized successfully with antibody-conjugated NP probes
to answer fundamental biological questions such as the
density and spatial distribution of cell surface receptors
[26,40-45].
Darkfield HS imaging measures spectral data across
sample with sensitivity to spectral changes
Before quantifying changes to NP spectra in a cellular
environment, we first verified that accurate spectra could
be obtained and spectral shifts could be detected with
sufficient sensitivity using a commercial CytoViva HS
Imaging System (CytoViva, Auburn, AL, USA). A dilute
solution of 100-nm spherical AuNPs was immobilized
onto a glass slide and imaged using the CytoViva HS Im-
aging System. The same field of view of the AuNP sub-
strate was imaged in air (n = 1.00), water (n = 1.33), and
glycerol (n = 1.47) for validation across a range of re-
fractive indices (RIs), including those found within a cell
(n = approximately 1.35 to 1.38) [46,47]. In air, water,
and glycerol, the NPs scattered light with a green, yel-
low, and yellow-orange color, respectively (Figure 1A).
This was expected since the NP plasmon resonance is
dependent on the RI of its local environment [20].
Figure 1B shows the measured scattering spectra of a
NP selected from the HS image in air, water, and gly-
cerol, illustrating the shift in the plasmon resonance to
longer wavelengths with an increase in the RI of the sur-
rounding medium. This shift agrees well with thatpredicted by Mie scattering theory for NPs well-
dispersed in a homogeneous dielectric environment
(Figure 1C). We further validated our system by analyz-
ing the scattering spectrum collected from HS images of
cells without NPs. The spectrum agreed with the charac-
teristic scattering response of cells, which monotonically
decreases with longer wavelengths of light (Figure 2).
Together, these results suggest that the CytoViva HS Im-
aging System can be utilized in this study to obtain ac-
curate cell spectra and plasmonic NP spectra with
enough sensitivity to detect even shifts due to changes
of RI.
Characterizing spectral shift in media prior to cell uptake
In order to quantify the changes in NP spectra that
occur when NPs are introduced to a cellular environ-
ment, we transferred citrate-stabilized 100-nm AuNPs
into complete cell culture media and incubated them
with cells. When NPs are transferred to complete cell
culture media, a protein corona can form on their sur-
face, and they may agglomerate; thus, even before cellu-
lar uptake, it is possible for there to be some shift in the
NP spectra. We characterized the shift in NP spectra
due to the transfer of NPs to cell culture media before
cellular uptake by using UV-vis extinction spectroscopy
(Figure 3A,B). The AuNPs originally had a resonance
peak wavelength of 569 nm in water. After transferring
the NPs into complete phenol red-free cell culture media
containing 10% human serum (CPRFM), the spectra
red-shifted 5 nm to a peak wavelength of 574 nm. Even
after 24 h of incubation in CPRFM, NP spectra cumula-
tively shifted no more than 6 nm to a peak wavelength
of 575 nm (Figures 3A,B, and Additional file 1: Figure S2).
These values agree well with previous reports of a 4- to 6-
nm shift by 10- to 80-nm AuNPs after 24 h in cell culture
media [48,49] and represent the shift in NP spectra pos-
sible before cellular uptake.
Quantifying shift in spectral peak wavelength of NPs
upon introduction to cellular environment
To quantify changes in the optical spectra of AuNPs fol-
lowing cellular uptake, we exposed human breast adeno-
carcinoma Sk-Br-3 cells to NPs in CPRFM. We chose to
use the Sk-Br-3 cell line because it is commonly used in
studies to demonstrate PTT [4,28]. After incubation
with NPs for up to 24 h, cells were rinsed thoroughly,
fixed, and characterized by darkfield HS imaging. We
measured the optical spectra from HS images by defin-
ing ROIs around either individual cells (‘cell ROI’) or
around each NPC within the cells (‘NPC ROI’).
Figure 3C,E shows representative HS images that illus-
trate how cell ROIs and NPC ROIs within those cell
ROIs were defined. Spectra integrated across representa-
tive ROIs are shown in Figure 3D,F. At this exposure
Figure 1 Darkfield hyperspectral (HS) data of AuNPs in various refractive index media to confirm spectral sensitivity. (A) HS images
(taken at 40x magnification) of 100-nm AuNPs immobilized on a glass slide and imaged in air (n = 1.00), water (n = 1.33), or glycerol (n = 1.47),
respectively. Inset shows a selected NP (or NP cluster) at higher magnification. (B) Scattering spectra extracted from HS image for a specific NP or
NP cluster indicated by a dotted rectangle in part A. (C) Theoretical scattering spectra calculated based on Mie scattering theory code for 100-nm
AuNPs in a homogeneous dielectric environment.
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showed red-shifting with respect to the original NP
spectra in water or CPRFM that was greater than could
be explained by simply the minor difference in RI of
water (n = 1.33) and the surrounding fluid within cells
(n = 1.35 ~ 1.38) [46,47] (Figure 3B,D,F; Figure 1B).Using the cell and NPC ROI analysis approaches, we
systematically quantified the spectral changes experi-
enced by NPs in a cellular environment as a function of
NP exposure duration and dose - two important param-
eters in administering NPs for biomedical applications.
HS images were taken after cells were exposed to 12, 24,
Figure 2 Darkfield HS image and spectrum of Sk-Br-3 cells
alone agrees with characteristic cell scattering spectra. (A) HS
image of Sk-Br-3 cells alone. (B) Normalized scattering spectrum of
representative cell from part A. Inset shows the cell region of interest
(ROI) over which the spectrum was collected.
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to study the extent to which spectra change and how
they change as a function of exposure duration and dose.
These NP exposure doses were chosen based on the doses
previously utilized in in vitro and in vivo plasmonic NP-
based biomedical studies [38,50] and the NP uptake cap-
acity of cells on a NPs-per-cell basis [22,30,51,52].
Spectral analysis based on cell ROIs showed that spec-
tra red-shifted with increasing exposure time and NP ex-
posure dose (Figure 4). Figure 5 shows representative
HS images, corresponding spectra, and cellular TEM im-
ages to illustrate the progression of changes observed in
HS images, spectra, and cellular TEM images after 2, 5,
10, and 24 h of NP exposure at the 24 μg/mL dose.Initially after only 2 h of NP exposure, few NPs were
observed to be associated with cells in HS images
(Figure 5A). Cellular TEM images indeed confirmed the
presence of only 0 or 1 NP on the cell surface or interior
of cell slices at t = 2 h (Figure 5A). Spectra extracted
from cell ROIs in the HS images showed monotonically
decreasing optical spectra, suggesting that cell scattering
dominated over the signal from the few NPs internalized
by cells at this early time point (Figure 5A). Interestingly,
at this early time point, spectra for the other low expos-
ure doses (12 and 48 μg/mL) were also dominated by
cell scattering. Only the highest exposure dose (96 μg/mL)
of NPs resulted in high enough NP uptake at 2 h to pro-
vide enough NP signal in the spectra and enable the spec-
tral peak wavelength to be determined (Figure 4).
After 5 h of exposure to NPs, a greater presence of NPs
was observed in association with some cells (Figure 5B).
Cellular TEM showed there were more NP-containing
vesicles in cells at this time than at t = 2 h; however, each
vesicle in the cell slice only contained 1 to 3 NPs and most
commonly only contained 1 NP (Figure 5B and Additional
file 1: Figure S3B. Note: Number of NPs in vesicles from
cell slices does not represent the total number of NPs in 3D
vesicles, but are provided to help in following relative
trends). Spectra extracted from cell ROIs in the HS images
taken at this time point were either still dominated by cell
scattering or showed a peak wavelength of 568.5 ± 7.7 nm.
After 10 h of NP exposure (Figure 5C), HS images showed
that the majority of cells contained a large number of
NPCs. Spectra from the HS images appeared broader and
shifted to longer wavelengths, with a mean peak wave-
length of 589.7 ± 10.3 nm. This corresponded well to the
increase in the number of NPs per NPC and proportion of
cells containing multiple NPCs (most visualized cell slices
contained 3 to 5 NPCs) observed by cellular TEM
(Figure 5C and Additional file 1: Figure S3C). Following
24 h of NP exposure (Figure 5D), nearly all cells in the HS
images contained areas with large numbers of NPCs, and
the mean spectral peak wavelength reached 625.4 ±
27.3 nm.
Overall, cell ROI spectral analysis showed that a mean
spectral shift of 54 to 79 nm was possible over 24 h at
the exposure doses studied here (Figure 4). At the lowest
dose of 12 μg/mL, cell ROI spectra showed peak wave-
lengths of 569.7 ± 7.8 and 623.2 ± 24.8 nm after 5- and
24-h NP exposure, respectively, for a total shift of 53.5 ±
26.0 nm (Figure 4). At the highest NP exposure dose
(96 μg/mL) tested, cell ROI spectra showed peak wave-
lengths of 566.0 ± 4.6 and 644.6 ± 23.0 nm after 2 and
24 h of NP exposure, respectively, for a total shift of ap-
proximately 78.6 ± 23.5 nm (Figure 4). At the exposure
doses used in this study, cells remained >97% viable
based on a Live/Dead viability assay, and therefore, the
measured spectral shifts represent shifts that are possible
Figure 3 Optical spectra for AuNPs before and after introduction to cellular environment. (A) Schematic illustration of the transfer of NPs
from water to complete phenol red-free cell culture medium (CPRFM) which results in protein corona formation and possible spectral shift prior
to cellular uptake. (B) UV-vis extinction spectra of NPs before transfer to CPRFM, immediately after transfer to CPRFM, and after 24 h of incubation
in CPRFM, showing minimal spectral shift in CPRFM prior to cellular uptake. (C) Representative darkfield HS image of Sk-Br-3 cells exposed to
24 μg/mL AuNPs for 24 h and (D) corresponding spectra extracted from the 10 representative cell ROIs denoted in part C. (E) Darkfield HS image
of part C's cell ROI 2 with 10 representative ROIs drawn around NP clusters (NPCs). (F) Optical scattering spectra measured from the 10 NPC ROIs
defined in part E. Number labels above spectra in parts D and F indicate range (minimum and maximum) of peak wavelengths. For clarity, only
10 representative ROIs are shown in parts C and E.
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Figure 4 Peak wavelengths for cell ROI spectra following NP exposure at various doses and durations. Cells were exposed to 12, 24, 48,
or 96 μg/mL AuNPs for 2, 5, 10, or 24 h. Peak wavelength increased (spectra red-shifted) with increasing NP exposure time and dose. To note, at
2 h, only cells exposed to the 96 μg/mL dose of AuNPs exhibited sufficient NP signal so that a peak wavelength could be determined. At all lower
exposure doses (12, 24, 48 μg/mL) at 2 h, the measured spectra was dominated by cell scattering so peak wavelengths could not be calculated
and are not shown. Error bars represent the standard error of the mean. Spectra were measured from 63 to 125 cells in each condition, but only spec-
tra with sufficient NP signal were included in the analysis (see ‘Methods’ section and Additional file 1 for details). **p < 0.01. Color of the horizontal line
underneath the **symbol indicates the exposure dose for which the comparison is made.
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(Additional file 1: Figure S4). Greater spectral shifts were
experienced when higher NP exposure doses were used:
After 5-h incubation, cells exposed to 96 μg/mL NPs
had a significantly greater peak wavelength than those
exposed to 12, 24, or 48 μg/mL NPs (Figure 4). At 10 h,
the 24, 48, and 96 μg/mL NP exposure doses had signifi-
cantly greater spectral peak wavelengths than those of
the 12 μg/mL exposure dose. Finally after 24-h exposure,
the 48 and 96 μg/mL doses achieved significantly greater
spectral peak wavelength than cells exposed to the 12
and 24 μg/mL doses (Figure 4). One of the reasons for
this finding may be that higher NP doses show faster up-
take by cells [22], which results in larger accumulation
of NPs. Additionally, NPs that are internalized early have
more time to be transported to larger intracellular vesi-
cles, thus forming large NPCs.
While TEM showed a continual increase in NP cluster
size inside cells with increasing exposure time (Figure 5
and Additional file 1: Figure S3), indicating that agglom-
eration of NPs within cellular endosomes contributes to
the spectral shift we measured, we cannot rule out the
possibility that some NPs may remain adsorbed to the
cell surface after rinsing. Therefore, the spectra we re-
port here represent the total contribution from both
internalized NPs as well as any NPs still on the cell ex-
terior. This situation is actually similar to what happenswhen metal NPs are introduced in vitro or in vivo, where
both internalized and cell surface-bound NPs will con-
tribute a plasmonic response upon illumination [53].
After 24 h, cell ROI spectra are heterogeneous
While Figure 4 shows the mean peak wavelengths exhib-
ited by cells following NP exposure, the distribution of
peak wavelengths across cells in a cell population is im-
portant for determining how homogenous of an optical
response can be achieved from cell to cell in a cell popu-
lation. Figure 6 depicts the distribution of spectral peak
wavelengths exhibited by the various cells of a cell popu-
lation and provides a sense of the range and degree of
heterogeneity of spectral peak wavelengths among cells.
For all exposure doses, cells incubated with NPs for 2, 5,
or 10 h showed a relatively narrow distribution of spec-
tral peak wavelengths, but after 24 h of NP incubation,
substantial heterogeneity in spectral peak wavelengths
exhibited by different cells was observed (Figure 6). For
example, cells exposed to 12 μg/mL of NPs for 24 h
showed spectra ranging from 573 to 696 nm in peak
wavelength (Figure 6). This large spread of peak wave-
lengths may be attributed to cells each being in different
stages of the cell cycle, with some cells just starting to
internalize NPs and other cells already having internal-
ized and processed NPs from early endosomes to late ly-
sosomes for a longer time. Diversity in the number of
Figure 5 Representative HS images, corresponding spectra, and TEM images through time following NP introduction to cells. Cells
were exposed to NPs at a dose of 24 μg/mL for (A) 2-, (B) 5-, (C) 10-, and (D) 24-h incubation. The continual increase in NP cluster size within
cells with increased exposure time seen in cellular TEM images suggests that intracellular agglomeration of NPs contributes to the measured
spectral shifts. Spectra are normalized to 1 for ease of comparison. HS images were taken at 5 μm above the slide plane to capture spectral
contributions from intracellular NPs (see ‘Methods’ section and Additional file 1).
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cently been reported [54], and we also observe this vari-
ability in NP distribution among cells in cellular TEM
images (Additional file 1: Figures S3, S5). Additionally,
heterogeneity in cellular uptake and agglomeration of
NPs has previously been reported for scavengerreceptor-mediated endocytosis of silver NPs by J774A.1
macrophage cells [45], similar to what we observed in
our general receptor-mediated endocytosis experimental
setup here. In summary, we observe that a cell popula-
tion exposed to NPs will exhibit an increasing diversity
in optical spectra with time. The increased heterogeneity
Figure 6 Distribution of spectral peak wavelengths measured from different cells of same population. Cells were exposed to (A) 12,
(B) 24, (C) 48, and (D) 96 μg/mL of AuNPs for 2, 5, 10, or 24 h. Cell ROI spectral peak wavelengths among different cells increase in diversity with
time. To note, at 2 h, only cells exposed to the 96 μg/mL dose of AuNPs (D) exhibited optical spectra for which a peak wavelength could be
determined. At all lower exposure doses (A, B, C) at 2 h, the measured spectra was dominated by cell scattering.
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portant to consider timing when exciting NPs for applica-
tions based on a cellular level optical response.
Cell ROI spectra broaden significantly between 10- and
24-h incubation
We next examined the broadness of the cell ROI spectra
since the broadness of the resulting spectra of NPs in
cells will impact the wavelength range in which the NPs
can be excited. We defined broadness by measuring thespectral width at 95% of the maximum intensity (‘spec-
tral width’). The mean spectral width ranged between
57.6 ± 6.4 and 76.8 ± 12.5 nm for all NP exposure doses
after 5- and 10-h incubation, respectively, but spectra
experienced further broadening (along with red-shifting)
after 24 h of cellular exposure to NPs (Figure 7). After
24 h of NP exposure, cell ROI spectra showed spectral
widths ranging from 103.4 ± 20.3 to 105.9 ± 11.7 nm for
the different exposure doses. Spectral width increased
significantly between early time points and 24 h of NP
Figure 7 Broadness of cell ROI spectra. Cells were exposed to 12, 24, 48, or 96 μg/mL of AuNPs for 2, 5, 10, or 24 h. Spectral broadness was
defined as the spectral width at 95% of maximum intensity (‘spectral width’). Spectral width increased significantly after 24 h of exposure
(** denotes p < 0.01). Shown are the mean and standard error of the mean. For each condition, spectra were analyzed from 63 to 125 cells. The
percent of cells exhibiting sufficient NP signal for analysis is also plotted. At low exposure dose and duration, only a small proportion of cells in
the cell population displayed sufficient NP signal since most cells had not yet internalized a substantial number of NPs at this time. Spectral width
was only analyzed for cells containing sufficient NP signal (not dominated by cell scattering); see Additional file 1 for details. Thus, at low
exposure doses and durations, the spectral width measurements reflect only the small subset of cells that had internalized NPs and thus had
sufficient NP signal to be analyzed.
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posed to 24 and 48 μg/mL exposure doses, the mean
spectral width decreased between 5 and 10 h. This may
be because at 5-h exposure, only a subset of cells in the
cell population had sufficient NP signal for spectral ana-
lysis (Figure 7, see ‘Methods’ section for how cells were
objectively classified as having sufficient NP signal for
analysis), and the mean spectral width thus only
reflected this specialized subpopulation. The relative
broadness of the cell ROI spectra suggests that a wider
range of wavelengths may be used to excite the NPs and
still achieve an optical scattering response with intensity
between 95% and 100% of that achieved at the peak
wavelength.
We attribute the broadening of spectra at t = 24 h
mainly to the longer period of time provided for cells to
accumulate NPs and process them into various endo-
somes and lysosomes, which contributes to larger
degrees of heterogeneities in the NPC sizes and geomet-
rical configurations in the cell ROI. The simultaneous
presence of newly endocytosed NPs of modest NPC sizes
and larger NPCs accumulated from an earlier time cre-
ates a range of NPCs confirmed by cellular TEM images(Additional file 1: Figure S3). Averaging of the disparate
spectra from the various NPC configurations inside the
cell plays a major role in increasing the broadening of
cell ROI spectra. The broadening is also contributed by
the complex spectral characteristics of individual large
NPCs, as will be discussed next.
NPC ROI spectra represent optical response from
individual NPCs
While cell ROI spectra reflect the overall optical re-
sponse from cells containing NPCs, they do not repre-
sent local spectral properties attributed by specific
NPCs. We defined ROIs around NPCs and hypothesized
that their corresponding spectra could provide a closer
measure of the plasmonic properties of specific NPCs
within cells. For optically triggered subcellular applica-
tions of AuNPs, this type of spectral information can be
important for knowing how NPCs will optically respond,
and if spectral overlap is of possible concern (by assessing
broadness of the NPC ROI spectra). We focused our ana-
lysis on the 24 μg/mL exposure dose at t = 2, 5, 10, and
24 h. For each time point, we analyzed at least 10 cells for
which we previously analyzed cell ROI spectra. Within
Figure 8 Electromagnetic simulations illustrating the complex spectral properties of large nanoparticle clusters. Normalized electric field
plot in log scale, i.e., log(normE), in the middle plane of clusters composed of 1, 2, 3, 7, and 12 spherical 3D AuNPs (diameter 100 nm). The
distance between adjacent AuNPs is between 5 and 20 nm. Inter-particle distances can be determined from the specific coordinates of the
AuNPs, listed in Additional file 1: Table S2. The surrounding medium is water. Polarization of the excitation is in the horizontal direction.
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(n = 56 to 180 NPC ROIs per condition).
Like the cell ROI spectra, NPC ROI spectra showed an
increasing red-shift of the peak spectral wavelength and
spectral broadening over time. At all exposure times,
NPC ROI spectra had greater mean peak wavelengths
than those measured from cell ROIs (Additional file 1:
Figure S6). We attribute the greater mean peak wave-
length of NPC ROI spectra to the decreased contribu-
tion of cell scattering in NPC ROI spectra, which are
only defined around individual NPCs. In other words,
because cell ROI spectra are measured by integrating
across a whole cell, cell ROI spectra may experience a
dampened red-shift caused by the cell scattering contri-
butions that have higher intensities at lower wavelengths
(Figure 2).
Spectral broadening was also observed from NPC
ROIs. Spectral width ranged from 48.7 ± 14.9 nm after
2-h NP exposure to 64.9 ± 24.5 nm after 24-h exposure
(Additional file 1: Figure S7B). After 24 h of cellular ex-
posure to NPs, NPC ROI spectra were significantly
broader than after 2, 5, or 10 h of exposure (Additional
file 1: Figure S7B, p < 0.01). We attribute this broadening
to the spectral properties of the larger NPCs seen in
TEM at t = 24 h (Additional file 1: Figure S3), as largeNPCs exhibit more complex spectral properties than
monomers and dimers due to the excitation of higher-
order modes [55]. Inter-particle coupling, which contrib-
utes to the overall optical response of a NPC, can be
wavelength-dependent; for larger NPCs, this coupling
can be manifested at a broad range of wavelengths red-
shifted from the plasmonic resonance of individual
AuNPs. Although it is difficult to recapitulate the NPC
configurations found in cells exactly with simulations,
we demonstrate the complex nature of inter-particle
coupling using a full-wave electromagnetic simulation
program COMSOL Multiphysics. We created five NPC
configurations resembling the most frequently observed
geometries in cellular TEM images (Additional file 1:
Figures S3, S5) and plotted the electric field between
AuNPs in the logarithmic scale at six excitation wave-
lengths from 550 to 800 nm (Figure 8). For a 100-nm
single AuNP in water, the peak resonance wavelength
was between 550 and 600 nm (first row of Figure 8),
consistent with the Mie calculation of 580 nm. For a
dimer structure with a 20-nm inter-particle gap, the res-
onance peak (i.e. strongest inter-particle coupling) is
red-shifted to between 650 and 700 nm (second row of
Figure 8). The larger 3-, 7-, and 12-NP clusters exhibit
various degrees of strong electric fields around/within
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fourth, and fifth row of Figure 8), illustrating how large
NPCs exhibit more complex spectral properties than
monomers and dimers. Spectral broadening can also
arise from other factors not characterized by simulations
in Figure 8. Major among these is the polarization of the
excitation light. Excitation polarized along different geo-
metrical axes of asymmetrical NPCs may generate dis-
tinct spectral shapes. Because our experiments were
performed with unpolarized light, the measured spectra
represent the averaging of spectra from different polari-
zations, and thus, broadening of the spectral shape.
Taken together, these effects support our observation
that even on a NPC level, spectra have broadened sig-
nificantly through time in a cellular environment.
Conclusions
In conclusion, we have quantified changes in the peak
wavelength, broadness, and distribution of AuNP spectra
after NPs are introduced to a cellular environment. As
creative, new biomedical applications utilizing the op-
tical properties of plasmonic NPs continue to be devel-
oped, it is important to understand how the NP spectra
change in a physiological environment. We have shown
that when 100-nm AuNPs are exposed to Sk-Br-3 breast
adenocarcinoma cells, an average shift of approximately
79 nm in the optical spectra can be achieved. As the in-
cubation time increases and cells have a chance to
process NPs into larger endosomal vesicles containing
multiple NPs (as indicated by TEM), the spectra con-
tinue to shift with time. At shorter incubation times
following NP exposure, smaller shifts were observed,
suggesting that the time at which the NPs are optically
excited is important to consider. For 100-nm AuNPs,
the NPC ROI spectral peak wavelength stays within
30 nm of its initial peak wavelength in the first 2 to 5 h
of incubation but shifts significantly between 10 and
24 h.
The spectral shift is also sensitive to the NP exposure
dose. Since NPs are internalized more quickly with
higher doses, a greater shift is experienced. Although we
measured a pronounced spectral shift with increasing
time and exposure dose, we found that the cellular level
spectra can also broaden significantly after 24 h of incu-
bation such that at least 95% of the maximum optical re-
sponse can be achieved with illumination wavelengths
within a 105-nm region around the spectral peak wave-
length. Given this magnitude of spectral broadening, it
may not be as necessary to precisely account for where
the peak wavelength is located when designing NP sys-
tems for applications based on a cellular level optical re-
sponse since a similar intensity of optical response may
be achieved using a wide range of wavelengths. However,
as methods for fabricating NPs with narrowerresonances are established, the broadening and shifting
of NP spectra in cells may merit consideration in the de-
sign of NP systems for multiplexing applications where
discrete NPs are excited.
The magnitude of spectral shifting and broadening ex-
perienced by NPs will likely vary for NPs with different
size and surface conjugation since these properties influ-
ence protein corona composition, cellular uptake speed,
and NP clustering dynamics within the cell. The HS im-
aging and analysis approaches utilized here may be ap-
plied to study how the optical spectra of other
nanostructures with varying morphologies are affected
by a cellular environment. Such studies can help build a
foundation for understanding and predicting how desig-
nable NP parameters such as size and surface functiona-
lization relate to the amount of shift and broadening
experienced.
To address potential agglomeration-associated red-
shifting and broadening of NPs, plasmonic NPs may be
designed to aggregate less or be separated a greater dis-
tance from other NPs when internalized within cells. For
example, NPs may be designed with a thick surface coat-
ing [56] that minimizes coupling of resonances within
endosomes and preserves the originally designed optical
NP spectra. Alternatively, further characterization of the
agglomeration and resulting changes to spectra for NPs
under a variety of physiological conditions can enable
these agglomeration-associated optical changes to be fac-
tored into the design of NPs for biomedical applications.
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